Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
5.40
-0.24 (-4.26%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ensysce Biosciences Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Ensysce Biosciences.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Ensysce Biosciences.
Recommendation Trends
Rating | May '23 | Jun '23 | Jul '23 | Aug '23 | Sep '23 |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 2 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $135 → $105 | Strong Buy | Maintains | $135 → $105 | +1,844.44% | Sep 25, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $135 | Strong Buy | Initiates | $135 | +2,400.00% | Jul 3, 2023 |
Lake Street | Lake Street | Strong Buy Maintains $14,400 → $1,440 | Strong Buy | Maintains | $14,400 → $1,440 | +26,566.67% | Nov 17, 2022 |
Lake Street | Lake Street | Strong Buy Initiates $14,400 | Strong Buy | Initiates | $14,400 | +266,566.67% | Nov 30, 2021 |
Financial Forecast
Revenue This Year
4.23M
from 2.23M
Increased by 89.78%
Revenue Next Year
n/a
from 4.23M
EPS This Year
-8.50
from -70.40
EPS Next Year
-13.03
from -8.50
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 4.5M | n/a | 84.0M | |
Avg | 4.2M | n/a | 47.8M | |
Low | 3.9M | n/a | 13.4M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 102.4% | - | - | |
Avg | 89.8% | - | - | |
Low | 75.7% | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -4.43 | -10.71 | 88.52 |
Avg | -8.50 | -13.03 | 85.99 |
Low | -12.20 | -15.03 | 82.61 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.